OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Thrombosis and Thrombolysis is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection	55
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team	42
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry	33
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series	27
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding	24
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients	23
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison	23
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum	16
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies	15
Metformin therapy in COVID-19: inhibition of NETosis	14
Forensic autopsy-confirmed thrombosis-related deaths: the danger in the bones	13
Popliteal cysts are not a risk factor for lower extremity deep vein thrombosis	12
The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis	12
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study	11
Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell’s viper venom time and silica clotting time increases thrombotic risk prediction	11
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism	11
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period	11
A survey of internists’ recommendations for aspirin in older adults and barriers to evidence-based use	10
Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type	10
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States	10
Activated clotting time in inpatient diagnostic and interventional settings	9
Modelling the procoagulatory effect of Anastrozole relative to ERα and ERβ expression in breast cancer cells	9
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes	9
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials	9
Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports	9

Contemporary use of ventilation-perfusion imaging for pulmonary embolism diagnosis	7
Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series	7
Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry	7
Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism	7
Acute coronary syndrome in patients with hemophilia: a delicate balancing act	7
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity	7
Correction to: Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension	7